The acquisition will expand Boston Scientific’s cardiovascular portfolio with a complementary and differentiated calcium modification platform, furthering the company's strategy to address coronary and peripheral disease.
A new study finds that generative AI can rapidly and accurately screen patients for clinical trial eligibility based on their medical records.
A study found that the type of transfusion approach used to support adults who developed anemia after a heart attack did not make a significant difference in their likelihood of having another heart attack or dying within 30 days.
Read More
In a new study, etripamil restored heart rate to normal within 30 minutes in 60.2% of the 188 verified paroxysmal supraventricular tachycardia episodes.
Read More
A phase 3 trial named REPRIEVE suggests that daily pitavastatin calcium can lead to a 35% relative reduction in major adverse cardiovascular events in patients with HIV receiving antiretroviral therapy. The trial, which enrolled a global sample, highlights the importance of cardiovascular disease prevention in HIV patients.
Read More
A networking group for cardiology fellows-in-training has proven effective in involving trainees in clinical trial programs. This model showcases the potential to enhance diversity and representation in trials, tackling existing gaps in enrollment and promoting equal participation.
Read MoreBristol Myers Squibb’s mavacamten receives FDA approval for updated labeling, showcasing its efficacy in reducing the need for septal reduction therapy in patients with obstructive hypertrophic cardiomyopathy based on positive data from the VALOR-HCM trial.
Read More
The IRONMAN trial investigates the safety and effectiveness of intravenous iron treatment in heart failure patients. Although the primary outcomes did not reach statistical significance, further analysis suggests a potential impact on heart failure hospitalizations and cardiac death. These findings contribute to the growing evidence supporting iron deficiency assessment and treatment in heart failure patients.
Read More